Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

61.83
Delayed Data
As of 4:00pm ET
 -0.02 / -0.03%
Today’s Change
46.01
Today|||52-Week Range
66.10
+0.90%
Year-to-Date
The Case For Buying Bristol-Myers Squibb
Jan 17 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at ...
Jan 12 / Zacks.com - Paid Partner Content
The Case For Bristol-Myers Squibb
Jan 17 / TheStreet.com - Paid Partner Content
Key Takeaways from Pfizer & 3 Other Drug Stocks at Healthcare Conference
Jan 11 / Zacks.com - Paid Partner Content
Lawson Kroeker Investment Management Inc Buys Costamare Inc, Sells Compass Minerals ....
Jan 17 / GuruFocus News - Paid Partner Content
Exelixis Amends Cabozantinib-Tecentriq Phase Ib Trial
Jan 05 / Zacks.com - Paid Partner Content
Exelixis, Ipsen Report Positive Results on Lead Cancer Drug
Jan 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close61.85
Today’s open61.81
Day’s range61.10 - 61.90
Volume7,904,177
Average volume (3 months)5,560,625
Market cap$101.2B
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+184.95%
Earnings growth (this year)+6.02%
Earnings growth (next 5 years)+10.45%
Revenue growth (last year)+17.31%
P/E ratio24.2
Price/Sales5.05
Price/Book6.36

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.02+0.05%
NVONovo Nordisk+0.10+0.18%
CELGCelgene-0.30-0.29%
LLYEli Lilly and Co-0.39-0.45%
Data as of 4:02pm ET, 01/18/2018

Financials

Next reporting dateFebruary 5, 2018
EPS forecast (this quarter)$0.67
Annual revenue (last year)$19.4B
Annual profit (last year)$4.5B
Net profit margin22.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts